NFKB1 and colitis: In particular, it was reported in murine DSS colitis that the activation of A3AR, expressed in colonic epithelia, exerts anti-inflammatory activity through the inhibition of the pro-inflammatory cytokine TNF and IL-1β via the inhibition of the NF-κB signaling pathways [12].